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Feeding and the circadian system regulate lipid absorption and metabolism, and the expression of enzymes involved in lipid
metabolism is believed to be directly controlled by the clock system. To investigate the interaction between the lipid metabolism
system and the circadian system, we analyzed the eﬀect of a CLOCK/BMAL1 heterodimer on the transcriptional regulation of
PPAR-controlled genes through PPAR response elements (PPREs). Transcription of acyl-CoA oxidase, cellular retinol binding
protein II (CRBPII), and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase was altered by CLOCK/BMAL1, and
transcriptional activity via PPRE by PPARs/RXRα was enhanced by CLOCK/BMAL1 and/or by PPARs ligand/activators. We also
found that CLOCK/BMAL1-mediated transcription of period (PER) and cryptochrome (CRY) was modulated by PPARα/RXRα.
These results suggest that there may be crosstalk between the PPARs/RXRα-regulated system and the CLOCK/BMAL1-regulated
system.
Copyright © 2008 Koh-ichi Nakamura et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Most living things, including humans, show a circadian
rhythm in their activities. The molecular mechanism of this
circadianrhythmhasrecentlybeenclariﬁed.Theﬁrstdiscov-
ery was identiﬁcation of the period (PER) gene in Drosophila
[1–3]. Later, the single minded (SIM) and aryl hydrocarbon
receptor nuclear translocator (ARNT) isoforms were discov-
ered in Drosophila, and ARNT was identiﬁed as a dioxin
receptor and as a transcription factor. Thereafter, the three
genes (PER, ARNT, and SIM) were shown to have iden-
tical domains, the so-called PAS domain [4]. In addition,
these transcription factors contain the basic-helix-loop-helix
(bHLH)-leucine zipper domains, and SIM and ARNT form
heterodimers [5]. Another variant of these genes was named
the CLOCK gene (CLOCK) by Takahashi et al. [6, 7]. More-
over, Ikeda et al. [8] cloned the brain and muscle Arnt-like
protein 1 (BMAL1) gene (BMAL1)f r o mb r a i na n dm u s c l e
tissue and demonstrated its homology to ARNT, including
possession of a bHLH-PAS domain. Recent studies using the
two-hybrid method have shown that BMAL1 forms a het-
erodimer with CLOCK. This CLOCK/BMAL1 heterodimer
can bind to the mouse PER gene (mPER) promoter region,
and act as a transcriptional regulator [9]. The base sequence
5 -CACGTG-3 , which is located in the promoter region, has
been named the E-box. There are three isoforms of the PER
gene (PER1,2,3). In addition, cryptochrome genes (CRY1,2)
have been identiﬁed [10]. Interacting positive and nega-
tive transcriptional-translational feedback loops have been
reported to drive circadian oscillations in both Drosophila
and mammals. The best-characterized feedback loop is in
the mouse and involves the regulation of three mPER1-3
and two mCRY1-2 genes [11]. It is now thought that tran-
scription of mPER and mCRY is driven by accumulating
CLOCK/BMAL1 heterodimers, which in turn bind to con-
sensus E-box elements (5 -CACGTG-3 )[ 9].
Theperoxisomeproliferator-activatedreceptor(PPAR)is
am e m b e ro ft h en u c l e a rr e c e p t o rs u p e r f a m i l y[ 12]. Three2 PPAR Research
types of PPARs have been described in rodents, humans,
and amphibians: PPARα,P P A R β (also called PPARδ), and
PPARγ.PP ARαisexpressedmostabundantlyintheliver[13]
and is associated with β-oxidation in the mitochondria and
peroxisomes. Although PPARβ/δ is expressed ubiquitously
[14], its functional role remains to be clariﬁed. Activation
of PPARα decreases the fatty acid content of cells through β-
oxidationoffattyacids,whereasPPARγisatranscriptionfac-
tor expressed selectively in adipose tissue [15] and seems to
be associated with adipocyte diﬀerentiation. Fenoﬁbric acid
i sas y n t h e t i cl i g a n do fP P A R α, and the thiazolidinedione
drugs such as troglitazone are synthetic ligands of PPARγ.
No synthetic ligands of PPARβ/δ are so far used clinically.
Steroid hormones such as dexamethasone have been
found to regulate these three PPARs. It is well known that
circulating concentrations of some steroids exhibit circadian
variability [16], and recent observations suggest that feeding
cycles are capable of regulating peripheral clocks indepen-
dent of light stimulation [17]. A recent study has also shown
thatthecircadianexpressionofthePPARgene(PPAR)isr eg-
ulatedbyperipheraloscillatorsinaCLOCK-dependentman-
ner [18]. Moreover, we have also shown that CLOCK and
BMAL1 play an important role in lipid homeostasis by reg-
ulating the circadian activation of potential PPAR response
element- (PPRE-) controlled target genes [19]. The partner
ofPPAR,RXR,interactswiththeCLOCKproteininaligand-
dependent manner and inhibits CLOCK/BMAL1-dependent
activation via an E-box element [20]. McNamara et al. also
recently reported that the retinoid X receptor (RXR) and
retinoic acid receptor (RAR) are capable of interacting with
MOP4 and CLOCK. MOP4 is a transcription factor, and is
also called NPAS2. MOP4 is a paralog of CLOCK [21, 22]
that can dimerize with BMAL1 and appears to function in
a clockwork mechanism in mouse forebrain. RXR has been
shown to bind to PPARs, resulting in formation of the het-
erodimer, which then binds to the peroxisome proliferator
response element (PPRE), thereby activating target genes in-
cluding those coding for acyl-CoA oxidase (AOX), lipopro-
tein lipase, acyl-CoA synthase, cellular retinol binding pro-
tein II (CRBPII), and 3-hydroxy-3-methylglutaryl coenzyme
A (HMG-CoA) synthase [23, 24].
In the present study, we used AOX, CRBPII, and HMG-
CoAsynthasepromoterreporterstoinvestigatewhethertheir
transcriptional activity is regulated by the CLOCK/BMAL1
heterodimer. We also investigated whether CLOCK/BMAL1
heterodimers are capable of modulating the expression of
PPAR/RXR-regulated genes through the endogenous factors
regulated by CLOCK/BMAL1.
2. MATERIALS AND METHODS
2.1. Reagents
Fenoﬁbric acid was provided by Kaken Pharmaceutical Co.
(Tokyo, Japan). We used 10μM fenoﬁbric acid as a PPARα
ligand in our experiments, a concentration that is below its
reported EC50 value [25].
Troglitazone was generously provided by Sankyo Co.
(Tokyo, Japan). The cytotoxicity of the compounds tested
was assessed by the trypan blue dye exclusion method.
2.2. DNAsequencing
DNA sequencing was performed with an automated se-
quencer (ABI PRISM 310 Genetic Analyzer; Perkin Elmer,
Foster City, Calif, USA). All DNA sequences were conﬁrmed
by reading both DNA strands.
2.3. Westernblotting
An Amersham ECL kit was used to perform Western blot-
ting to detect speciﬁc immunoreactivity. Brieﬂy, heat-treated
15μg samples of CLOCK/BMAL1 were subjected to 10%
sodium dodecylsulfate polyacrylamide-gel electrophoresis
and transferred to nitrocellulose membranes (Millipore) by
semidry blotting. Molecular weight was determined by using
markers (RAINBOW Molecular Weight Markers, RPN800;
Amersham Biosciences, Buckinghamshire, UK). Antibodies
against the proteins coded by the human clock genes PER1,
PER2, CRY1, and CRY2 were obtained from Santa Cruz
Biotechnology (Calif, USA).
Membranes were treated overnight with TBS-Tween:
5% dry milk and incubated for 1 hour with 1000-fold di-
luted goat antibodies to human PER1, PER2, CRY1, and
CRY2. After washing, the membranes were incubated with
horseradish-peroxidase-conjugated rabbit antigoat mono-
clonal antibodies. Antigen detection was performed with a
chemiluminescence detection system.
2.4. HumanPPARα,PP ARγ1,RXRα,CL OCK,
andBMAL1expressionconstructs
DNA fragments encoding full-length human PPARα
(Genebank L-02932), PPARγ1 (Genebank L-40904), and
RXRα (Genebank X-52773) cDNAs were ampliﬁed from
skeletal muscle cDNA (no. 9514, Takara Shuzo Co., Ltd.,
Kyoto, Japan) or liver cDNA (no. 9505, Takara Shuzo Co.,
Ltd.) and ligated into pCR2.1 (Invitrogen). For PPARα, the
1407bp Sal I/Not I fragment was subcloned into the Sal
I/Not I site of pCI-neo (Promega), and the vector was named
pCI-PPARα.P P A R γ1 was subcloned into the Sal I/Not Is i t e
of the vector, and the vector was named pCI-PPARγ1. RXRα
was also subcloned into the Xho I/Not I site of the same
vector, and the vector was named pCI-RXRα.
Human full-length cDNAs for CLOCK and BMAL1 were
generated by the method reported previously [26]. The
cDNA fragments for CLOCK and BMAL1 were subcloned
into the Sal I/Not I site of pcDNA3 (Invitrogen, Calif, USA),
and the vectors were named pc-CLOCK and pc-BMAL1, re-
spectively.
2.5. Luciferasereporterassay
Transienttransfectionsforthereporterassaywereperformed
withTfx-50reagent(Promega)byfollowingtheprotocolrec-
ommended by the manufacturer. 293T human kidney cellsKoh-ichi Nakamura et al. 3
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Figure 1: Delations of PPAR response elements (5 -AG(G/T)TCA-3 ) from the promoter region of the cellular retinol binding protein II
(CRBPII)-Luc plasmid.
(293Tcells),CV-1monkeykidneycells(CV-1cells),NIH3T3
cells, and COS-1 cells were used because of their high trans-
fection eﬃciency.
All luciferase reporter assays were performed using
charcoal-dextran-treated medium (no. SH30068.03; Hy-
Clone, Utah, USA). When medium is treated with char-
coal, bioactive factors, such as testosterone, thyroxine, tri-
iodothyronine, vitamin A, 1,25-dihydroxy-vitamin D, and
17β-estradiol, are adsorbed by the charcoal, and the con-
centration of all these hormones is greatly reduced (as
stated in the manufacturer’s protocol). Since all these hor-
mones act through nuclear receptors such as PPAR, all
luciferase-reporter assays were performed using charcoal-
dextran-treated medium.
We used AOX, CRBPII, and HMG-CoA synthase pro-
moterregions [24]ligatedinto theKpn I/NcoI sites of pGL3-
Basic (Promega) upstream of the luciferase gene, and called
these constructs pAOX-Luc, pCRBPII-Luc, and pHMG-Luc,
respectively. Typically, genes (3μg) were inserted into 1×106
cells in 100-mm dishes for pAOX-Luc, pCRBPII-Luc, or
pHMG-Luc, and for pCI-PPARα, pCI-PPARγ1, pCI-RXRα,
pcDNA-CLOCK, or pcDNA-BMAL1. To measure transcrip-
tion rates induced by PPARs/RXRα and CLOCK/BMAL1 via
the E-box, we used the promoter region of mPER1 cloned
into the Kpn I/Nco I sites of pGL3-Basic upstream of the lu-
ciferase gene, a construct named pPER-Luc. There are three
E-box elements (5 -CACGTG-3 ) in the promoter region
(about 2,000 base pairs) of mPER1 [26].
pPPRE-Luc, pCRBPII-Luc, pHMG-Luc or pPER-Luc,
together with pRL-TK, in the presence or absence of
pCI-PPARα, pCI-PPARγ1, pCI-RXRα,p c D N A - C L O C K ,o r
pcDNA-BMAL1 vectors, were cotransfected into cells which
were grown in 24-well plates. The total amount of DNA
transfected (0.6μg) was normalized with a carrier DNA
(pCI-neo or pcDNA3). After 24 hours, cells were stimu-
lated with the PPARs ligand/activator for another 24 hours.
Finally, luciferase activity for pAOX-Luc, pCRBPII-Luc,
pHMG-Luc, or pPER-Luc was normalized to Renilla lu-
ciferase activity. All these activities were measured according
to the manufacturer’s instructions (Promega).
2.6. Transienttransfection/cotransfection
pCI-PPARα (3μg), pCI-PPARγ1( 3 μg), pCI-RXRα (3μg),
pcDNA-CLOCK (3μg), or pcDNA-BMAL1 (3μg) were tran-
sientlytransfectedinto1×106 cellsin100mmdishesbyusing
Tfx-50 Reagent (Promega) according to the manufacturer’s
instructions. After 24 hours, the cells were stimulated with a
testcompoundfor24hoursandwerethenanalyzedbyWest-
ern blot assay.
2.7. DeletionmodelsfortheCRBPII-Lucplasmid
(seeFigure1),pAOX-Lucplasmid,
andpHMG-Lucplasmid
The CRBPII gene promoter (5 -gtgtcccactctgctgtcacAGG
TCAcAGGTCAcAGGTCAcAGTTCAttttcctgtctctgtc-3 ,
from −670 to +63) contains four (5 -AG(G/T)TCA-3 )
repeat sequences [23]. We determined whether or not the
action of CLOCK and BMAL1 on the CRBPII promoter was
dependent on the number of AGGTCA sequences. Dele-
tions were introduced into the CRBPII-Luc plasmid (from
−670 to +63) by the PCR method or with the Exo/Mung
Bean Deletion kit (Stratagene, Calif, USA) to generate
the following reporter constructs: del-0-CRBPII-Luc (5 -
cctgtctctgtc-3 ,f r o m−599 to +63), del-1-CRBPII-Luc
(5 -cAGGTCAttttcctgtctctgtc-3 ,f r o m−610 to +63), del-
2-CRBPII-Luc (5 -cAGGTCAcAGGTCAttttcctgtctctgtc-3 ,
from −617 to +63), del-3-CRBPII-Luc (5 -cAGGTCAc
AGGTCAcAGGTCAttttcctgtctctgtc-3 ,f r o m−624 to +63),
and del-4-CRBPII-Luc (5 -cAGGTCAcAGGTCAcAGGTCA
cAGGTCAttttcctgtctctgtc-3 ,f r o m−631 to +63). The del-
0-CRBPII-Luc plasmid contained no (5 -AG(G/T)TCA-3 )
repeat sequences; the del-1-CRBPII-Luc plasmid contained
one (5 -AG(G/T)TCA-3 ) repeat sequence; the del-2-
CRBPII-Luc plasmid contained two (5 -AG(G/T)TCA-3 )
repeat sequences; the del-3-CRBPII-Luc plasmid contained
three (5 -AG(G/T)TCA-3 ) repeat sequences, and the del-4-
CRBPII-Luc plasmid contained four (5 -AG(G/T)TCA-3 )
repeat sequences.4 PPAR Research
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Figure 2: Dose-dependent alteration by the CLOCK/BMAL1 gene (0–220ng) of the transcriptional activity of PPARα/RXRα mediated
throughPPRE(5 -AGGTCA-3 )elementslocatedinthepromoterofacyl-CoAoxidase(AOX)inhumankidney293Tcellsincharcoal-treated
medium. Alteration by the CLOCK/BMAL1 gene alone (a), plus the PPARα/RXRα gene (50ng) (b), and plus the PPARα ligand/activator
fenoﬁbric acid (10μM) (c) in activity of transcription by PPARα/RXRα through PPRE (5 -AGGTCA-3 ) elements located in the promoter
of AOX. Luciferase activity for pAOX-Luc was normalized to the luciferase activity of pRL-TK. Experiments were performed in triplicate,
and four independent experiments were performed. All data are means ± SD.
Deletions were also introduced into the pAOX-Luc plas-
mid or pHMG-Luc plasmid to generate reporter constructs
by the same methods as for the deletions of the CRBPII-Luc
plasmid.
2.8. Statisticalanalysis
Fourindependentexperimentswereperformed,andeachex-
perimentwasperformedintriplicate.Parametricdataareex-
pressed as the mean ± standard deviation (SD). Diﬀerences
betweengroupswereevaluatedbyScheﬀ´ e’sFtest.Diﬀerences
were analyzed by repeated-measures ANOVA.
3. RESULTS AND DISCUSSION
To determine whether there is crosstalk between the PPRE-
mediatedtranscriptionsystemandtheE-box-mediatedtran-
scriptionsystem,weﬁrstmeasuredtranscriptionalactivation
of the target genes by PPARs/RXRα and CLOCK/BMAL1 via
PPRE. All the experiments were performed with human kid-
ney 293T cells and CV-1 monkey kidney cells. Because in-
troduction of pAOX-Luc and pCRBPII-Luc into human kid-
ney 293T cells, and of pHMG-Luc into CV-1 monkey kid-
ney cells, was particularly eﬃcient, only these results are pre-
sented.
TheeﬀectofCLOCK/BMAL1(seeFigure 2)ontranscrip-
tional activity of AOX (pAOX-Luc) was determined by a
reporter gene assay in 293T cells. PPARα/RXRα-mediated
transcription of the AOX gene via PPRE in 293T cells
was enhanced in charcoal-treated medium by cotransfection
with the CLOCK/BMAL1 expression constructs (0∼30ng).
Unexpectedly, the enhanced PPARs/RXRα-mediated tran-
scription of the AOX gene was signiﬁcantly decreased
by cotransfection of higher amounts (30∼9 0 n g )o ft h e
CLOCK/BMAL1 expression constructs in charcoal-treated
medium (seeFigure 2). When luciferase-reporter assays were
performed using medium not treated with charcoal-dextran,
the results were the exact opposite. Thus, diﬀerent results
are obtained depending on whether the sample is treated
or is not treated with charcoal-dextran (data not shown).
Thereareindicationsthatserumstimulationcanregulatethe
transcription of clock genes [27], and the levels of factorsKoh-ichi Nakamura et al. 5
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Figure 3: Western blotting analysis demonstrating changes in Period 1 (PER1), Period 2 (PER2), Cryptochrome 1 (CRY1), and Cryp-
tochrome 2 (CRY2) protein levels in the cytosol and nucleus by the CLOCK/BMAL1 gene (0–100ng). Experiments were performed in
triplicate, and four independent experiments were performed. A typical set of data is shown.
regulating such genes may be altered in culture media when
samples are treated with charcoal-dextran. Shirai et al. [28]
have reported that PPARα is involved in circadian clock con-
trol independently of the suprachiasmatic nucleus (SCN),
which is the central clock in mammals. Therefore, it is
possible that a PPAR ligand acts on the expression of
CLOCK/BMAL1, and that consistent results depend on the
complete removal of this ligand from the serum used.
The retinoid receptors RXR and RAR are capable of
interacting with MOP4 and CLOCK [20]. The dimin-
ished PPARs/RXRα-mediated transcription caused by co-
transfection of larger amounts of the CLOCK/BMAL1
heterodimer (30∼90ng) may be attributable to binding
b e t w e e nC L O C Ka n dR X R α. However, binding between
CLOCKandRXRαdoesnotappeartooccuraftercotransfec-
tion of smaller amounts of the CLOCK/BMAL1 heterodimer
(0∼30ng), indicating that there may be an optimal ratio
of CLOCK/BMAL1 to PPARα/RXRα. The CLOCK, BMAL1,
PPARα,a n dR X R α gene products form heterodimers via
the bHLH domain to act as transcription factors. As men-
tioned above, McNamara et al. have reported that the part-
ner RXRα gene product for PPARα can bind to CLOCK, re-
sulting in decreased transcriptional activity of PPARα [20].
P r e v i o u s l y ,w eh a v ef o u n dt h a tR X R α can bind to CLOCK
and, further, that PPARα can bind to CLOCK. In addition,
PPARα can bind to BMAL1, and RXRα can bind to CLOCK.
The binding aﬃnities of these interactions are diﬀerent (In-
oue I: Crosstalk between PPARα/RXRα gene and clock gene
(BMAL1/CLOCK). 35th, Japan Atherosclerosis Society, Ky-
oto , September, 2003). The relative transcriptional activities
ofthevariousheterodimersofCLOCK,BMAL1,PPARα,and
RXRα remain to be determined.
We performed a Western blot analysis of 293T cells
transfected with various amounts of CLOCK/BMAL1
(0∼100ng). The increase in CRY1 and PER1 protein levels
in the nucleus peaked at the 30ng dose of CLOCK/BMAL1
(see Figure 3). Transcription of the mPER and mCRY
genes is now thought to be induced by accumulating
CLOCK/BMAL1 heterodimers, which, in turn, bind to con-
sensusE-boxelements.AconsensusE-boxelementispresent
in the promoter of the PER and CRY genes. That is,
the CLOCK/BMAL1 heterodimer binds to the E-box, 5 -
CACGTG-3 , located in the promoterregions ofthe PER and
CRY genes, such that the PER and CRY genes can be reg-
ulated by the CLOCK/BMAL1 heterodimer. The PER and
CRY gene products have been shown to inhibit the bind-
ing of CLOCK/BMAL1 to consensus E-box elements of the
PER and CRY genes, resulting in a reduction in the tran-
scriptional activity of these genes [9, 29, 30]. From our re-
sults, DNA binding of the CLOCK/BMAL1 heterodimer can
be regulated by the protein products of the PER and CRY
genes, suggesting that the PER and CRY gene products can
alter the transcriptional activity of the AOX, CRBPII, and
HMG-CoA synthase genes via their PPRE. Further research
is necessary to conﬁrm this suggestion. Oishi et al. [18]h a v e
reported that CLOCK is involved in the transactivation of
PPARα.Thereisthepossibilitythatincreasedproteinexpres-
sion of PPARα caused by the CLOCK gene acts directly on
thePPRE.TheincreasesinendogenousPER1andCRY1pro-
tein levels induced by exogenous CLOCK/BMAL1 may de-
crease the PPRE-mediated transcriptional activity of AOX.
AnotherreportsuggeststhatCRYiscapableofactingdirectly
on CLOCK/BMAL1, which would mean that CRY is capable
of regulating the gene expression of CLOCK/BMAL1 [31].6 PPAR Research
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Figure 4: Dose-dependent changes in activity of PPARα/RXRα-mediated transcription via the acyl-CoA oxidase (AOX) deletion pro-
moter by the CLOCK/BMAL1 gene (0–90ng) in human kidney 293T cells. Alterations in PPRE-mediated transcription of AOX by the
CLOCK/BMAL1 gene alone (a), plus the PPARα/RXRα gene (50ng) (b), and plus the PPARα ligand/activator fenoﬁbric acid (10μM) (c).
The luciferase activity of del-pAOX-Luc was normalized to the luciferase activity of pRL-TK. The del-AOX-Luc plasmid contained no repeat
sequences (5 -AGGTCA-3 ). Experiments were performed in triplicate, and four independent experiments were performed. All data are
means ± SD.
Our results suggest that the promoter transcriptional activity
of pCRBPII could be modulated by the CLOCK and BMAL1
genes within the dose range 0–100ng. However, the change
in pCRBPII promoter transcriptional activity induced by the
CLOCK and BMAL1 genes also showed the same tendency
over the dose range 100–220ng (data not shown), suggesting
a similar mechanism of action.
The pAOX-Luc construct contains six (5 -AGGTCA-3 )
repeat sequences, and when all six (5 -AGGTCA-3 )r e p e a t
sequences were deleted, no change in transcriptional activity
of the AOX promoter was observed in 293T cells transfected
with the same amounts of CLOCK/BMAL1 in charcoal-
treated medium (see Figure 4).
As stated above, the CRBPII promoter also contains
four (5 -AG(G/T)TCA-3 ) repeat sequences, and when all
four (5 -AG(G/T)TCA-3 ) repeat sequences were deleted,
no change in transcriptional activity of the CRBPII pro-
moter was observed in 293T cells transfected with the
same amounts of CLOCK/BMAL1 in charcoal-treated
medium (see Figure 5). When the CRBPII promoter con-
taining one repeat sequence (5 -cAGTTCAt-3 ), two re-
peat sequences (5 -cAGGTCAcAGTTCAt-3 ), or three re-
peat sequences (5 -cAGGTCAcAGGTCAcAGTTCAt-3 )w a s
transfected, the change in transcriptional activity of the
CRBPII promoter gradually increased in 293T cells trans-
fected with the same amounts of CLOCK/BMAL1. WhenKoh-ichi Nakamura et al. 7
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experiments were performed. All data are means ± SD.
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Figure 6: The eﬀect of the CLOCK/BMAL1 heterodimer on PPARα target genes. Dose-dependent changes in activity of the 3-hydroxy-
3-methylglutaryl coenzyme A (HMG-CoA) synthase promoter (a) induced by the CLOCK/BMAL1 gene (0–140ng) in the presence and
absence of fenoﬁbric acid (10μM) in CV-1 monkey kidney cells plus the PPARα/RXRα gene (50 ng). When the promoter of the HMG-CoA
synthase gene did not contain direct repeat sequences (del-pHMG-Luc), no change in transcriptional activity of the HMG-CoA synthase
promoter was observed (b). The luciferase activity of pHMG-Luc was normalized to the luciferase activity of pRL-TK. Experiments were
performed in triplicate, and four independent experiments were performed. All data are means ± SD.8 PPAR Research
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Figure 7: The eﬀect of the CLOCK/BMAL1 heterodimer on PPARγ
target genes. Changes in activity of PPARγ1/RXRα-mediated
(50ng) (a) transcription of the cellular retinol binding protein II
(CRBPII) promoter by the CLOCK/BMAL1 gene (50ng) in human
kidney 293T cells in the presence and absence of the PPARγ lig-
and/activator troglitazone (0–30μM). The del-0-CRBPII-Luc plas-
m i dc o n t a i n e dn or e p e a ts e q u e n c e s( 5  -AG(G/T)TCA-3 ). The lu-
ciferase activity of pCRBP-Luc was normalized to the luciferase ac-
tivity of pRL-TK. Experiments were performed in triplicate, and
four independent experiments were performed. All data are means
± SD. ∗P <.05 versus cells not transfected with theCLOCK/BMAL1
gene. Diﬀerences were analyzed by repeated-measures ANOVA.
0
2
4
6
8
10
L
u
c
i
f
e
r
a
s
e
a
c
t
i
v
i
t
y
(
r
e
l
a
t
i
v
e
u
n
i
t
)
05 0 0 5 0
(ng)
50
(ng)
pPER-Luc
PPARα
RXRα
CLOCK
BMAL1
∗
∗
∗
(a)
0
2
4
6
8
10
L
u
c
i
f
e
r
a
s
e
a
c
t
i
v
i
t
y
(
r
e
l
a
t
i
v
e
u
n
i
t
)
05 0 0 5 0
(ng)
50
(ng)
pPER-Luc
PPARγ1
RXRα
CLOCK
BMAL1
∗
∗
∗
(b)
Figure 8: Inhibition of CLOCK/BMAL1 by PPARα and PPARγ1.
The PPARα/RXRα (a) gene (50ng) and the PPARγ1/RXRα (b) gene
(50ng) abolished activation of the Period1 (Per1)p r o m o t e rb yt h e
CLOCK/BMAL1 gene (0–50ng) in human kidney 293T cells in
the presence of the PPARα ligand/activator fenoﬁbric acid (10μM)
(a) and PPARγ ligand/activator troglitazone (10μM) (b). The lu-
ciferase activity of pPER-Luc was normalized to the luciferase ac-
tivity of pRL-TK. Experiments were performed in triplicate, and
four independent experiments were performed. All data are means
± SD. ∗P < .05 versus cells not transfected with the PPARα/RXRα
geneorPPARγ1/RXRαgene.Diﬀerenceswereanalyzedbyrepeated-
measures ANOVA.Koh-ichi Nakamura et al. 9
transfected with promoter containing four repeat sequences
(5 -cAGGTCAcAGGTCAcAGGTCAcAGTTCAt-3 ), the ex-
pected change in transcriptional activity of the CRBPII pro-
moter was observed in 293T cells transfected with the same
amounts of CLOCK/BMAL1 (see Figure 5).
AsimilartendencywasobservedinCV-1cellstransfected
with the promoter of the HMG-CoA synthase gene (see
Figure 6(a)), which contains direct (5 -AAAAACTGGGCCA
aAGGTCT-3 ) repeat sequences [24]. When these direct (5 -
AAAAACTGGGCCAaAGGTCT-3 ) repeat sequences were
deleted from the promoter of the HMG-CoA synthase gene,
no change in transcriptional activity of the HMG-CoA syn-
thase promoter was observed in CV-1 cells transfected with
the same amounts of CLOCK/BMAL1 in charcoal-treated
medium (see Figure 6(b)).
A similar tendency toward changes in transcriptional
activity of the CRBPII promoter (see Figures 7(a), 7(b))
was observed when the PPARγ ligand/activator troglitazone
was added. Transcription of AOX, CRBPII, and HMG-CoA
synthase was increased by CLOCK/BMAL1, and the tran-
scriptional activity via the PPRE of PPARs/RXRα was en-
hanced by CLOCK/BMAL1 and/or PPARs ligand/activator.
These results shown in Figures 6 and 7 clearly indicate that
CLOCK/BMALheterodimeractsasapositivefunctionalreg-
ulator of PPARα and PPARγ1. However, it is not clear that
whether CLOCK/BMAL heterodimer directly reacts with the
promoter regions of target genes of PPARs, or bounds to the
PPARs /RXRα proteins themselves.
Next, to determine whether the eﬀect of CLOCK/BMAL1
on transcription of mPER is modulated by PPARα/RXRα
or PPARγ1/RXRα, we investigated the eﬀect of the
CLOCK/BMAL1 gene on transcription of the PER gene in
239T cells. Transcription of the mPER1 gene was altered
by co-transfection with the CLOCK/BMAL1 gene (see Fig-
ures 8(a), 8(b)); and by cotransfecting PPARα/RXRα (see
Figure 8(a))o rP P A R γ1/RXRα, (see Figure 8(b)) we also
found that the PPARα/RXRα or PPARγ1/RXRα genes mod-
ulate transcription of mPER indicating that PPARα/RXRα
and PPARγ1/RXRα function in the negative regulators of the
CLOCK/BMAL1-dependent transcriptions. Recently, Shirai
et al. [32] reported that ligands for PPARα and PPARγ do
not signiﬁcantly aﬀect the transcriptional activity of the
mouse PER gene. In our study, transcriptional activation of
the mPER gene by the CLOCK/BMAL1 gene was altered by
transfection of the PPARα/RXRα and PPARγ/RXRα genes
comparedwiththatofthecontrol,inapparentcontradistinc-
tion to the results of Shirai et al. However, we used charcoal-
treated medium, which would not contain intrinsic ligands
for PPARα,P P A R γ,a n dR X R α making the diﬀerence be-
tween the two sets of results diﬃcult to interpret.
We believe that the change in transcriptional activity of
AOX, CRBPII, and HMG-CoA synthase caused by the pres-
ence of the CLOCK/BMAL1 heterodimer may be regulated
via the PPRE (5 -AGGTCA-3 ). The PPRE is the site of ac-
tion not only of PPARα/RXRα but also of PPARβ/RXRα and
PPARδ/RXRα.
In conclusion, the results of this study suggest that there
is crosstalk between binding to the PPRE and binding to
the E-box by the CLOCK/BMAL1 gene and by the PPARα/
RXRα or PPARγ/RXRα genes, and that modulation of the
PPRE by the CLOCK/BMAL1 gene aﬀects the activity of the
PPARα/RXRα gene, the PPARγ/RXRα gene, and/or PPARα/γ
ligand/activators.
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